Baum Hedlund’s Track Record against GSK
Our firm has pursued personal injury, wrongful death and consumer class action cases against GSK for over 15 years. In fact, we have filed more than 3,500 individual cases against GSK involving Paxil personal injury and wrongful death, Paxil pediatric class actions, Avandia heart attacks, and now handle Zofran birth defect cases.
Over the course of litigating cases against GSK, our firm has collected hundreds of thousands of pages of internal GSK documents and conducted dozens of depositions of GSK executives, employees, physicians, researchers and academics. As a result, our firm knows how GSK operates, knows its tactics, the players, and how to get the evidence needed to effectively prosecute cases against GSK.
While representing our clients, a Baum Hedlund Zofran lawyer will dig deep into pharmaceutical company files to discover the truth about what the company knew about the drug’s risks, when the company knew of those risks and what efforts, if any, the company took to hide those risks. Only through legal action can anyone gain access to this type of information, as acknowledged in a Wall Street Journal article written about our firm on June 20, 2008, U.S. Probe of Glaxo’s Paxil Widens.
For example, our firm uncovered a sophisticated ghostwriting program, known as CASPPER, which GSK used to promote its antidepressant Paxil, allowing doctors to take credit for medical journal articles mainly written by GSK consultants. According to the CASPPER memo, which dates from April 2000, the program was designed to “strengthen the product positioning and overcome competitive issues.”